BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22322570)

  • 1. Ex vivo and preclinical assessment of an endothelial progenitor cell capturing bioengineered stent.
    Yazdani SK; Kolodgie FD; Virmani R
    Minerva Cardioangiol; 2012 Feb; 60(1):11-21. PubMed ID: 22322570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial progenitor cell capture stent: safety and effectiveness.
    Sethi R; Lee CH
    J Interv Cardiol; 2012 Oct; 25(5):493-500. PubMed ID: 22612275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genous endothelial progenitor cell-capturing stent system: a novel stent technology.
    Klomp M; Beijk MA; de Winter RJ
    Expert Rev Med Devices; 2009 Jul; 6(4):365-75. PubMed ID: 19572791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
    Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
    Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
    Lim WH; Seo WW; Choe W; Kang CK; Park J; Cho HJ; Kyeong S; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2798-805. PubMed ID: 22015656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis.
    Lev EI; Leshem-Lev D; Mager A; Vaknin-Assa H; Harel N; Zimra Y; Bental T; Greenberg G; Dvir D; Solodky A; Assali A; Battler A; Kornowski R
    Eur Heart J; 2010 Nov; 31(21):2625-32. PubMed ID: 20543191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Chong E; Poh KK; Liang S; Lee RC; Low A; Teo SG; Tan HC
    J Interv Cardiol; 2010 Apr; 23(2):101-8. PubMed ID: 20236214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of endothelial progenitor capture cell stent during percutaneous treatment of coronary bifurcations: a prospective angiographic registry.
    Rognoni A; Secco GG; Lupi A; Santagostino M; Sansa M; Bongo AS; Rognoni G
    Crit Pathw Cardiol; 2011 Dec; 10(4):189-92. PubMed ID: 22089276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent thrombosis of drug eluting stent: pathological perspective.
    Nakazawa G
    J Cardiol; 2011 Sep; 58(2):84-91. PubMed ID: 21839616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of current devices and a look at new technology: drug-eluting stents.
    Nakazawa G; Finn AV; Kolodgie FD; Virmani R
    Expert Rev Med Devices; 2009 Jan; 6(1):33-42. PubMed ID: 19105778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis.
    George J; Herz I; Goldstein E; Abashidze S; Deutch V; Finkelstein A; Michowitz Y; Miller H; Keren G
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):e57-60. PubMed ID: 14615392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to accelerate the endothelialization of stents.
    Ong AT; Aoki J; Kutryk MJ; Serruys PW
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):123-6. PubMed ID: 15787303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent.
    Klomp M; Beijk MA; Damman P; Woudstra P; Koch KT; Tijssen JG; de Winter RJ
    J Interv Cardiol; 2011 Oct; 24(5):442-9. PubMed ID: 22004602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
    Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.